A Mother’s Gift of Life: Successful Living-Donor Kidney Transplant Restores Hope for 32 Years old Young CKD Patient from Bangladesh
HYDERABAD, India, Nov. 24, 2025 /PRNewswire/ -- In an inspiring story of…
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal…
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE…